Annalisa Jenkins
Director · Skye Bioscience, Inc.
Individual
- 2024
- Apr 2, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Annalisa Jenkins files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 5AM Partners VII, LLC - $445K in SKYE purchases and sales in the last 12 months
- Andrew J. Schwab - $445K in SKYE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Annalisa Jenkins?
Annalisa Jenkins is a corporate insider, tracked as Director of Skye Bioscience, Inc. (SKYE). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Annalisa Jenkins last file a Form 4?
The most recent primary Form 4 on record is dated 2 April 2026, one of 4 filings going back to 2024.
